184 related articles for article (PubMed ID: 36444392)
21. Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients.
Kodra Y; Giustini S; Divona L; Porciello R; Calvieri S; Wolkenstein P; Taruscio D
Dermatology; 2009; 218(3):215-20. PubMed ID: 19088462
[TBL] [Abstract][Full Text] [Related]
22. Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.
Bicudo NP; Germano CMR; de Moraes RT; de Avó LRDS; Ferner RE; Melo DG
An Bras Dermatol; 2024; 99(4):520-526. PubMed ID: 38493052
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.
Ferner RE; Thomas M; Mercer G; Williams V; Leschziner GD; Afridi SK; Golding JF
Health Qual Life Outcomes; 2017 Feb; 15(1):34. PubMed ID: 28193237
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with parental knowledge of neurofibromatosis type 1 (NF1): Parental affected status and genetic counseling.
Solem EP; Primiano M; McQuillen MP; Zak Goelz M
J Genet Couns; 2020 Dec; 29(6):1151-1158. PubMed ID: 32196829
[TBL] [Abstract][Full Text] [Related]
25. Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.
Ahlawat S; Ly KI; Fayad LM; Fisher MJ; Lessing AJ; Berg DJ; Salamon JM; Mautner VF; Babovic-Vuksanovic D; Dombi E; Harris G; Plotkin SR; Blakeley J;
Neurology; 2021 Aug; 97(7 Suppl 1):S111-S119. PubMed ID: 34230200
[TBL] [Abstract][Full Text] [Related]
26. Executive functions and quality of life in children with neurofibromatosis type 1.
Roy A; Roulin JL; Gras-Le Guen C; Corbat ML; Barbarot S
Orphanet J Rare Dis; 2021 Oct; 16(1):420. PubMed ID: 34627329
[TBL] [Abstract][Full Text] [Related]
27. Health Survey of Adults with Neurofibromatosis 1 Compared to Population Study Controls.
Fjermestad KW; Nyhus L; Kanavin ØJ; Heiberg A; Hoxmark LB
J Genet Couns; 2018 Sep; 27(5):1102-1110. PubMed ID: 29429039
[TBL] [Abstract][Full Text] [Related]
28. [Quality of life in children with neurofibromatosis type 1, based on their mothers' reports].
Saltık S; Başgül ŞS
Turk Psikiyatri Derg; 2013; 24(1):25-34. PubMed ID: 23446537
[TBL] [Abstract][Full Text] [Related]
29. The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1.
Chilibeck CM; Shah S; Russell HC; Vincent AL
Ophthalmic Genet; 2021 Jun; 42(3):223-229. PubMed ID: 33594930
[No Abstract] [Full Text] [Related]
30. Pain, skin sensations symptoms, and cognitive functioning predictors of health-related quality of life in pediatric patients with Neurofibromatosis Type 1.
Varni JW; Nutakki K; Swigonski NL
Qual Life Res; 2019 Apr; 28(4):1047-1052. PubMed ID: 30465317
[TBL] [Abstract][Full Text] [Related]
31. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
[TBL] [Abstract][Full Text] [Related]
32. The self-concept of children and adolescents with neurofibromatosis type 1.
Barton B; North K
Child Care Health Dev; 2007 Jul; 33(4):401-8. PubMed ID: 17584395
[TBL] [Abstract][Full Text] [Related]
33. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
Wimmer K
Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
[TBL] [Abstract][Full Text] [Related]
34. The health-related quality of life of children, adolescents, and young adults with neurofibromatosis type 1 and their families: Analysis of narratives.
Draucker CB; Nutakki K; Varni JW; Swigonski NL
J Spec Pediatr Nurs; 2017 Apr; 22(2):. PubMed ID: 28198162
[TBL] [Abstract][Full Text] [Related]
35. Attitudes about internet support groups among adolescents and young adults with neurofibromatosis type 1 and their parents.
Martin S; Wolters PL; Baldwin A; Roderick MC; Toledo-Tamula MA; Gillespie A; Widemann B
J Genet Couns; 2014 Oct; 23(5):796-804. PubMed ID: 24469442
[TBL] [Abstract][Full Text] [Related]
36. Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.
Cohen JS; Levy HP; Sloan J; Dariotis J; Biesecker BB
Clin Genet; 2015 Nov; 88(5):425-30. PubMed ID: 25534182
[TBL] [Abstract][Full Text] [Related]
37. Understanding the Neurofibromatosis Type 1 (NF1) experience and the priorities of individuals with NF1 and their caregivers for cognitive and social-emotional research.
Del Castillo A; Dekarchuk M; Inker T; Hussey M; Walsh KS
J Psychiatr Res; 2022 Oct; 154():268-277. PubMed ID: 35964345
[TBL] [Abstract][Full Text] [Related]
38. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
Lorenzo J; Barton B; Arnold SS; North KN
J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
[TBL] [Abstract][Full Text] [Related]
39. Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents.
Domon-Archambault V; Gagnon L; Benoît A; Perreault S
J Child Neurol; 2018 Mar; 33(3):225-232. PubMed ID: 29318935
[TBL] [Abstract][Full Text] [Related]
40. [Phenotypic and genetic features in neurofibromatosis type 1 in children].
Duat Rodríguez A; Martos Moreno GÁ; Martín Santo-Domingo Y; Hernández Martín A; Espejo-Saavedra Roca JM; Ruiz-Falcó Rojas ML; Argente J
An Pediatr (Barc); 2015 Sep; 83(3):173-82. PubMed ID: 25541118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
